|

Best Supportive Care (BSC) Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 3: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Metastatic Castration-resistant Prostate Neoplasms1
  • Cancer1

La Jolla, California1 trial

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

University of California at San Diego

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.